Be a part of 8^th International Conference on Digestive and Gastrointestional Diseases

Track 1: Gastroenterology & Digestive Health: Comprehensive insights into the prevention, diagnosis, and management of common and complex digestive disorders across diverse populations.

Track 2: Hepatology and Liver Diseases: Latest advances in liver disease research, diagnostics, and personalized treatment strategies for acute and chronic hepatic conditions.

Track 3: Viral Hepatitis: Diagnosis, Management & Elimination: Emerging therapies, public health strategies, and precision approaches toward hepatitis prevention, control, and global elimination.

Track 4: Gastrointestinal Pathology & Molecular Diagnostics: Innovations in histopathology, biomarkers, and molecular tools enabling accurate diagnosis and personalized GI care.

Track 5: Gastrointestinal Oncology & Precision Cancer Care: Advances in early detection, molecular profiling, and targeted therapies for GI malignancies.

Track 6: Post-COVID and Emerging Infections in Gastroenterology: Understanding the long-term gastrointestinal impacts of COVID-19 and novel infectious diseases on digestive health.

Track 7: Small Bowel and Colonic Disorders: Diagnosis and management of inflammatory, functional, and structural disorders affecting the small intestine and colon.

Track 8: Pancreatic and Biliary Diseases: Clinical and translational updates on pancreatic disorders, gallbladder disease, and biliary tract conditions.

Track 9: Esophageal and Gastric Disorders: State-of-the-art approaches to reflux disease, motility disorders, infections, and gastric pathologies.

Track 10: Abdominal Disorders and Primary Care Integration: Collaborative care models linking gastroenterology with primary care for early diagnosis and improved patient outcomes.

Track 11: Gut Microbiota, Microbiome & Probiotics: Exploring microbiome science, host–microbe interactions, and microbiota-based therapies in GI health and disease.

Track 12: Celiac Disease and Gluten-Related Disorders: Advances in diagnosis, management, and emerging therapies for celiac disease and non-celiac gluten sensitivity.

Track 13: Pediatric Gastroenterology and Nutrition: Focused discussions on digestive disorders, growth, and nutrition in infants, children, and adolescents.

Track 14: Innovation, Technology & AI in Gastroenterology: Breakthroughs in AI, digital health, advanced endoscopy, and precision technologies shaping the future of GI care.

The global market for digestive and gastrointestinal (GI) disease diagnostics and therapeutics is experiencing steady growth, driven by the rising prevalence of GI disorders such as inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), liver diseases, colorectal cancer, and functional gastrointestinal disorders. Changing lifestyles, aging populations, increasing obesity rates, and dietary habits are contributing significantly to the global digestive disease burden.

Advancements in precision medicine, genomics, microbiome research, artificial intelligence, and minimally invasive technologies are transforming gastroenterology care. The growing adoption of advanced endoscopic procedures, AI-assisted imaging, biomarker-based diagnostics, and personalized therapeutics is accelerating market expansion. Additionally, increased awareness, early screening programs, and improved access to healthcare in emerging economies are fueling demand for innovative GI solutions.

The Middle East, particularly the UAE and Gulf region, is emerging as a strategic hub for healthcare innovation, clinical research, and medical tourism. Strong government investment in healthcare infrastructure, digital health initiatives, and international collaborations is creating new opportunities for gastroenterology research, technology providers, and pharmaceutical companies. This conference provides a vital platform for stakeholders to analyze market trends, share insights, and foster collaborations that will shape the future of precision gastroenterology and personalized digestive care.